PepGen (PEPG) EPS (Basic) (2021 - 2026)

PepGen (PEPG) posted EPS (Basic) of -$0.26 for Q1 2026, up 40.65% sequentially from -$0.43 in Q4 2025, and up 72.19% YoY from -$0.15 in Q1 2025.

PepGen (PEPG) EPS (Basic) (2021 - 2026) Analysis & Trends

PepGen has reported EPS (Basic) for 6 years, with the latest figure at -$0.26 in Q1 2026.

Quarterly EPS (Basic) rose 72.19% year-over-year to -$0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.12 (up 64.49% YoY) and the FY2025 annual result came in at -$2.12, up 25.47% from the prior year.
EPS (Basic) improved to -$0.26 in Q1 2026 per PEPG's latest filing, from -$0.43 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.26 in Q1 2026 and troughed at -$18.94 in Q1 2022.
A 5-year average of -$1.94 and a median of -$0.79 in 2022 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2022 and 2023: EPS (Basic) sank 177.09% in 2022, then soared 96.37% in 2023.
Over 5 years, EPS (Basic) stood at -$2.96 in 2022, then jumped by 72.44% to -$0.82 in 2023, then increased by 11.32% to -$0.72 in 2024, then soared by 40.15% to -$0.43 in 2025, then jumped by 40.65% to -$0.26 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.26, -$0.43, and -$0.52 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	4.34
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	12.62
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	7.59
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-3.06
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.16
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	0.00
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.18
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.23
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.06
10	PepGen	207.09 Mn	207.09 Mn	-	-0.26

Download Data